NCT06584864

Brief Summary

The aim of the study is to assess the influence of ultrasound examination of the lumbar spinal canal on the effectiveness of lumbar puncture. An open-label, randomized interventional study.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
0mo left

Started Mar 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress97%
Mar 2024Jun 2026

Study Start

First participant enrolled

March 1, 2024

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

August 2, 2024

Completed
1 month until next milestone

First Posted

Study publicly available on registry

September 5, 2024

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2026

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2026

Expected
Last Updated

July 30, 2025

Status Verified

July 1, 2025

Enrollment Period

2 years

First QC Date

August 2, 2024

Last Update Submit

July 29, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Obtaining cerebrospinal fluid after the first attempt at lumbar puncture

    Obtaining cerebrospinal fluid after the first attempt at lumbar puncture (at least 0.5 ml in volume, with a red blood cell count of \<10,000/mm3).

    1 day

Secondary Outcomes (7)

  • obtaining cerebrospinal fluid - < 10,000/mm3 - at any attempt

    1 day

  • obtaining cerebrospinal fluid - > 10,000/mm3 - at any attempt

    1 day

  • total number of puncture attempts to obtain cerebrospinal fluid

    1 day

  • unsuccessful puncture - failure to obtain cerebrospinal fluid

    1 day

  • duration of puncture

    1 day

  • +2 more secondary outcomes

Study Arms (2)

Utrasound group

EXPERIMENTAL

Bedside ultrasound examination of the lumbar spinal canal before lumbar puncture

Diagnostic Test: bedside ultrasound examination of the lumbar spinal canal

Standard group

NO INTERVENTION

Standard procedure group

Interventions

The ultrasound examination will be performed using a Lumify linear probe (frequency range 4-12 MHz). In the longitudinal projection, the doctor will assess the spinal cord endings by marking them with a sterile marker - a horizontal line on the patient's back. In the same projection, the doctor will designate a safe and optimal place (the greatest width of the dural sac) for performing a lumbar puncture by marking it with a sterile marker. Additionally, in the longitudinal projection, the researcher will measure the depth from the skin surface to the dura mater. Then, in the transverse projection, the doctor will confirm the absence of the spinal cord at the planned puncture site and the optimal amount of cerebrospinal fluid in the selected space. This information will be passed on to the operator, who will ultimately decide on the lumbar puncture site.

Utrasound group

Eligibility Criteria

AgeUp to 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • children \<18 years of age
  • patients who are scheduled to undergo lumbar puncture
  • consent of legal guardian

You may not qualify if:

  • infection of skin and tissues in the area of planned puncture
  • developmental defects of the spine and spinal cord
  • lack of consent of legal guardian
  • contraindications to lumbar puncture

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Medcial Univeristy of Warsaw

Warsaw, 02-091, Poland

RECRUITING

MeSH Terms

Conditions

Meningitis

Condition Hierarchy (Ancestors)

Neuroinflammatory DiseasesNervous System Diseases

Study Officials

  • Agata Ćwiek, MD

    Medical University of Warsaw

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Agata - Ćwiek, MD

CONTACT

Maciej - Kołodziej, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
open-label study
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Model Details: Open-label, randomized interventional study
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 2, 2024

First Posted

September 5, 2024

Study Start

March 1, 2024

Primary Completion

March 1, 2026

Study Completion (Estimated)

June 1, 2026

Last Updated

July 30, 2025

Record last verified: 2025-07

Locations